| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIC.200200492 |
| P698 | PubMed publication ID | 12794857 |
| P2093 | author name string | Andrew D Miller | |
| Natalya Lozovaya | |||
| P2860 | cites work | Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor | Q22254872 |
| Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor | Q24294731 | ||
| Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs | Q24294766 | ||
| Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein | Q24296266 | ||
| Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease | Q24303455 | ||
| A protein kinase involved in the regulation of inflammatory cytokine biosynthesis | Q24311139 | ||
| Expression cloning of a human corticotropin-releasing-factor receptor | Q24311371 | ||
| CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. | Q24594971 | ||
| Structure of interleukin 1 alpha at 2.7-A resolution | Q27684125 | ||
| Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution | Q27700151 | ||
| Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta | Q27734947 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
| Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies | Q28144742 | ||
| Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier | Q72429000 | ||
| Glucocorticoid feedback regulation of adrenocortical responses to neural stimuli: role of CRF-41 and corticosteroid type I and type II receptors | Q72666606 | ||
| Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretion | Q72798779 | ||
| Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? | Q72824707 | ||
| Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure | Q73067345 | ||
| Corticotropin-releasing factor--immunolabeled fibers in brain regions with localized kainate neurotoxicity | Q73285153 | ||
| The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat | Q73694899 | ||
| Neural-immune interactions in health and disease | Q73923416 | ||
| Valine 571 functions as a regional organizer in programming the glucocorticoid receptor for differential binding of glucocorticoids and mineralocorticoids | Q77895494 | ||
| Mechanistic investigation into complementary (antisense) peptide mini-receptor inhibitors of cytokine interleukin-1 | Q80525286 | ||
| Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders | Q40864089 | ||
| The role of interleukin-1 in disease | Q40879400 | ||
| A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses. | Q40896776 | ||
| Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines | Q40929370 | ||
| Pharmacophore development for corticotropin-releasing hormone: new insights into inhibitor activity. | Q40944017 | ||
| Aging is associated in the 344/N Fischer rat with decreased stress responsivity of central and peripheral catecholaminergic systems and impairment of the hypothalamic-pituitary-adrenal axis | Q40967835 | ||
| Body fat distribution, insulin resistance, and metabolic diseases | Q28248535 | ||
| Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 | Q28279735 | ||
| The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response | Q28281893 | ||
| Primary structure and expression of a functional human glucocorticoid receptor cDNA | Q28282278 | ||
| The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical | Q28285254 | ||
| Cytokines and the nervous system. I: Expression and recognition | Q28287817 | ||
| Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor | Q28584057 | ||
| Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor | Q29397110 | ||
| On the Role of Brain Mineralocorticoid (Type I) and Glucocorticoid (Type II) Receptors in Neuroendocrine Regulation | Q29544273 | ||
| Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety | Q29615160 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Brain corticosteroid receptor balance in health and disease | Q29620564 | ||
| Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study. | Q32112824 | ||
| Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30 | Q33577261 | ||
| Latent N-methyl-D-aspartate receptors in the recurrent excitatory pathway between hippocampal CA1 pyramidal neurons: Ca(2+)-dependent activation by blocking A1 adenosine receptors | Q33679109 | ||
| Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects | Q33692610 | ||
| Visceral obesity and diabetes | Q33781652 | ||
| HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment | Q33824172 | ||
| Central/peripheral nervous system and immune responses | Q33833798 | ||
| Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist | Q33836551 | ||
| Interleukin-6 expression and regulation in astrocytes | Q33850723 | ||
| Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor | Q33903826 | ||
| Glucocorticoids and immune function | Q33974265 | ||
| Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease | Q34112417 | ||
| Shock and tissue injury induced by recombinant human cachectin | Q34189904 | ||
| A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle | Q34311076 | ||
| Stress-induced neuroendocrine modulation of viral pathogenesis and immunity | Q34313147 | ||
| Penetration of interleukin-6 across the murine blood-brain barrier | Q34317844 | ||
| Cytokines and the brain corticosteroid receptor balance: relevance to pathophysiology of neuroendocrine-immune communication. | Q34341731 | ||
| Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors | Q34344852 | ||
| A portrait of Alzheimer secretases--new features and familiar faces | Q34345559 | ||
| Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. | Q34347790 | ||
| Solution structure of human corticotropin releasing factor by 1H NMR and distance geometry with restrained molecular dynamics. | Q34355771 | ||
| The role of the amygdala in fear and anxiety | Q34401070 | ||
| In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation | Q34409048 | ||
| Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm | Q72244516 | ||
| Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm | Q72319605 | ||
| Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate | Q72387905 | ||
| The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress | Q34487255 | ||
| Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart | Q34522183 | ||
| Specific interactions between sense and complementary peptides: the basis for the proteomic code | Q34580902 | ||
| Domain structure of the glucocorticoid receptor protein | Q34634498 | ||
| Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. | Q34740438 | ||
| Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation | Q35204601 | ||
| Interleukin-6 and its receptor: a paradigm for cytokines | Q35425050 | ||
| The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist | Q36071317 | ||
| Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats | Q36145363 | ||
| Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami | Q36241458 | ||
| Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure | Q36279657 | ||
| Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia | Q36357020 | ||
| Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder | Q36449700 | ||
| Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart | Q36682369 | ||
| Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. | Q36683828 | ||
| Monovalent phage display of human interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in the hIL-6 D-helix. | Q36791536 | ||
| Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor | Q37265547 | ||
| Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? | Q37354483 | ||
| Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis | Q37456977 | ||
| Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: circular dichroism and prediction studies | Q37510624 | ||
| Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor | Q37642640 | ||
| Corticosteroids and the brain. | Q38008826 | ||
| Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site. | Q38308440 | ||
| Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion | Q38318463 | ||
| Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. | Q39173722 | ||
| Tumor necrosis, cachexia, shock, and inflammation: a common mediator | Q39532135 | ||
| The role of corticotropin-releasing factor in the pathogenesis of major depression | Q39652692 | ||
| The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications | Q39794500 | ||
| Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions* | Q40172536 | ||
| The dexamethasone suppression test for melancholia | Q40342019 | ||
| Anti-inflammatory actions of steroids: molecular mechanisms | Q40386939 | ||
| The toxicity in vitro of beta-amyloid protein | Q40422520 | ||
| Evidence for an immune response in major depression: a review and hypothesis | Q40501767 | ||
| The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
| Glucocorticoids and the genesis of depressive illness. A psychobiological model | Q40577990 | ||
| Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. | Q40610100 | ||
| A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity | Q40665083 | ||
| Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo | Q40683266 | ||
| Corticosterone modulates interleukin-evoked fever in the rat. | Q40702039 | ||
| The DST as a predictor of outcome in depression: a meta-analysis | Q40768542 | ||
| Functional implications of brain corticosteroid receptor diversity. | Q40786578 | ||
| Neuronal injury associated with HIV-1: approaches to treatment | Q40858582 | ||
| Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells | Q41060700 | ||
| Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor. | Q41084575 | ||
| The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression | Q41086135 | ||
| Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. | Q41129657 | ||
| Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes | Q41175477 | ||
| Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I. | Q41256511 | ||
| Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? | Q41310086 | ||
| Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis | Q41344771 | ||
| CRH and the immune system | Q41355419 | ||
| Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. | Q41510527 | ||
| Behavioral Sensitization to Ethanol: Genetics and the Effects of Stress | Q41527799 | ||
| Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients | Q41561553 | ||
| Human TNF mutants with selective activity on the p55 receptor. | Q41578169 | ||
| The role of corticotropin-releasing hormone in neuroendocrine-immune interactions | Q41606498 | ||
| Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein | Q41613043 | ||
| Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. | Q41710815 | ||
| Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones | Q41784037 | ||
| Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor | Q41839655 | ||
| Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: Neuroendocrine activity and corticosteroid receptors | Q42050571 | ||
| Interleukin-6 and the Interleukin-6 Receptor in the Human Adrenal Gland: Expression and Effects on Steroidogenesis1 | Q42440887 | ||
| Chronic corticosterone treatment maintains synaptic activity of CA1 hippocampal pyramidal cells: acute high corticosterone administration increases action potential number | Q42478878 | ||
| The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat. | Q42487842 | ||
| Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation | Q42498419 | ||
| Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? | Q42509220 | ||
| Induction of interleukin-1 beta mRNA and enkephalin mRNA in the rat adrenal gland by lipopolysaccharides studied by in situ hybridization histochemistry. | Q42512599 | ||
| Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis | Q42515023 | ||
| Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants | Q42528252 | ||
| Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists | Q42552786 | ||
| 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling | Q42611750 | ||
| The effects of psychological stress on plasma interleukin-6 activity in rats | Q42637480 | ||
| Antagonism in the human mineralocorticoid receptor. | Q42646468 | ||
| Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis | Q42762750 | ||
| Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus | Q43411792 | ||
| Microbiology. Do chronic diseases have an infectious root? | Q43424702 | ||
| Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease | Q43665736 | ||
| Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils | Q43718666 | ||
| Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity. Role of severity of depressive symptoms and alcohol consumption | Q44030212 | ||
| Immunoreactive interleukin-1 beta localization in the rat forebrain | Q44061849 | ||
| Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. | Q44923542 | ||
| Evidence for the involvement of the central adrenergic system in interleukin 1-induced adrenocortical response | Q44936782 | ||
| Induction of Adrenocorticotropic Hormone Release by Interleukin‐6 In Vivo and In Vitroa | Q44994012 | ||
| Amygdaloid Lesions: Differential Effect on Conditioned Stress and Immobilization-Induced Increases in Corticosterone and Renin Secretion | Q45164337 | ||
| Glucocorticoids Inhibit Glucose Transport and Glutamate Uptake in Hippocampal Astrocytes: Implications for Glucocorticoid Neurotoxicity | Q45939833 | ||
| Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study | Q45978449 | ||
| Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism | Q46103373 | ||
| Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors | Q46282440 | ||
| Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits | Q46319902 | ||
| Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse | Q46373184 | ||
| Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor | Q46409186 | ||
| Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus | Q46534296 | ||
| A structural role for hormone in the thyroid hormone receptor. | Q46828407 | ||
| Age-dependent loss of corticosterone modulation of central serotonin 5-HT1A receptor binding sites | Q47816527 | ||
| Glucocorticoid receptor alpha and beta isoforms are not mutated in bipolar affective disorder | Q47859483 | ||
| The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation | Q47963060 | ||
| Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. | Q47963500 | ||
| The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression | Q47965029 | ||
| Corticotropin-releasing hormone and inflammation | Q47966912 | ||
| Interleukin-1 immunoreactive innervation of the human hypothalamus | Q48088092 | ||
| Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. | Q50938276 | ||
| Glutamate release in severe brain ischaemia is mainly by reversed uptake. | Q51977738 | ||
| Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels | Q52014469 | ||
| Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications | Q52051754 | ||
| Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. | Q52164855 | ||
| Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. | Q52174134 | ||
| Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. | Q52195685 | ||
| Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain. | Q52201229 | ||
| Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. | Q52235332 | ||
| Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. | Q52516700 | ||
| Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway. | Q52520403 | ||
| A role for a helical connector between two receptor binding sites of a long-chain peptide hormone. | Q52974117 | ||
| Chronic restraint enhances interleukin-1-beta release in the basal state and after an endotoxin challenge, independently of adrenocorticotropin and corticosterone release. | Q53847086 | ||
| Activation of the hypothalamic-pituitary-adrenal axis differentially affects the anti-mycobacterial activity of macrophages from BCG-resistant and susceptible mice. | Q54195539 | ||
| A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors. | Q54634083 | ||
| Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers | Q56767487 | ||
| Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression | Q56767554 | ||
| Interleukin-1 in adrenal chromaffin cells | Q56828047 | ||
| Central corticotropin releasing factor reduces natural cytotoxicity Time course of action | Q57174892 | ||
| Role of Hypothalamic Histaminergic Neurons in Mediation of ACTH and Beta-Endorphin Responses to LPS Endotoxin in vivo | Q57682233 | ||
| Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry | Q59216305 | ||
| Endotoxin and Interleukin 1 Decrease the Affinity of Hippocampal Mineralocorticoid (Type I) Receptor in Parallel to Activation of the Hypothalamic-Pituitary-Adrenal Axis | Q60628233 | ||
| β-AMYLOID FRAGMENT POTENTIATES IL-6 AND TNF-α SECRETION BY LPS IN ASTROCYTES BUT NOT IN MICROGLIA | Q61389728 | ||
| A canonical structure for the ligand-binding domain of nuclear receptors | Q61818643 | ||
| Interleukins-1 and -6 Stimulate the Release of Corticotropin-Releasing Hormone-41 from Rat Hypothalamusin Vitrovia the Eicosanoid Cyclooxygenase Pathway* | Q67912166 | ||
| Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins | Q67912168 | ||
| A heat shock protein complex isolated from rabbit reticulocyte lysate can reconstitute a functional glucocorticoid receptor-Hsp90 complex | Q68026046 | ||
| Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? | Q68166537 | ||
| Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner | Q68367814 | ||
| Differential effects of recombinant interleukin-1 alpha and beta on Leydig cell function | Q68454622 | ||
| Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo | Q68724997 | ||
| Bidirectional transport of interleukin-1 alpha across the blood-brain barrier | Q69425218 | ||
| Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus | Q69738440 | ||
| Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression | Q69742012 | ||
| Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder | Q70122282 | ||
| Nuclear receptors spring into action | Q70907169 | ||
| Chronic exposure to stress levels of corticosterone alters GABAA receptor subunit mRNA levels in rat hippocampus | Q71377544 | ||
| Increased pituitary activation following metyrapone administration in post-traumatic stress disorder | Q71460810 | ||
| Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts | Q71568514 | ||
| Effects of psychological stress on joint inflammation and adrenal function during induction of arthritis in the Lewis rat | Q71612739 | ||
| The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases | Q71674774 | ||
| Detection of interleukin-1 bioactivity in various brain regions of normal healthy rats | Q71727364 | ||
| Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion | Q48091347 | ||
| Local Cerebral Glucose Utilization Is Increased in Acutely Adrenalectomized Rats | Q48091454 | ||
| The hypothalamus-pituitary--adrenocortical axis: epigenetic determinants changes with aging, involvement of NGF. | Q48098712 | ||
| Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats | Q48138649 | ||
| Enhancement of glutamate release uncovers spillover-mediated transmission by N-methyl-D-aspartate receptors in the rat hippocampus | Q48172657 | ||
| Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis | Q48281498 | ||
| Estrogens normalize the hypothalamic-pituitary-adrenal axis response to stress and increase glucocorticoid receptor immuno-reactivity in hippocampus of aging male rats | Q48283785 | ||
| Distribution of interleukin 1 beta immunoreactivity within the porcine hypothalamus | Q48303945 | ||
| Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies | Q48311430 | ||
| Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro | Q48325217 | ||
| The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system | Q48377406 | ||
| Stress-induced changes of gene expression in the paraventricular nucleus are enhanced in spontaneously hypertensive rats | Q48401945 | ||
| Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system | Q48408490 | ||
| Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation | Q48433814 | ||
| Protein synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rats | Q48435298 | ||
| Dexamethasone augments ischemia-induced extracellular accumulation of glutamate in gerbil hippocampus | Q48436976 | ||
| Excitotoxic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain | Q48443531 | ||
| Glucocorticoids may alter antioxidant enzyme capacity in the brain: kainic acid studies | Q48447461 | ||
| Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release | Q48456362 | ||
| Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. | Q48457521 | ||
| Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami | Q48459080 | ||
| Differential modulation of Purkinje cell activity by enkephalin and corticotropin releasing factor | Q48464321 | ||
| Involvement of Arachidonic Acid Cascade Pathways in lnterleukin-6-Stimulated Corticotropin-Releasing Factor Release in vitro | Q48471146 | ||
| Regulation of hippocampal theta activity by corticosterone: opposing functions of mineralocorticoid and glucocorticoid receptors | Q48480136 | ||
| The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier | Q48487204 | ||
| Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats | Q48487944 | ||
| Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems | Q48490054 | ||
| Dexamethasone aggravates ischemia-induced neuronal damage by facilitating the onset of anoxic depolarization and the increase in the intracellular Ca2+ concentration in gerbil hippocampus | Q48513191 | ||
| The release of immunoreactive interleukin-1 beta from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormone | Q48566546 | ||
| Activation of the hypothalamic serotoninergic system by central interleukin-1. | Q48610830 | ||
| Influence of interleukin-6 on neural activity and transcription of the gene encoding corticotrophin-releasing factor in the rat brain: an effect depending upon the route of administration | Q48669021 | ||
| Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus | Q48702601 | ||
| Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats | Q48787582 | ||
| Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. | Q48845874 | ||
| Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent | Q48860341 | ||
| NMDA receptor-mediated synapses between CA1 neurones: activation by ischaemia. | Q48863955 | ||
| The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain | Q48878293 | ||
| Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid | Q49018315 | ||
| Involvement of central histamine in the early phase of ACTH and corticosterone responses to endotoxin in rats. | Q49097424 | ||
| Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action | Q49097455 | ||
| Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. | Q50526066 | ||
| Bed nucleus of the stria terminalis: cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat. | Q50888338 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 466-484 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems | |
| P478 | volume | 4 |
| Q37594725 | A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older adults |
| Q37002385 | Inflammation and neuropeptides: the connection in diabetic wound healing |
| Q36468282 | Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms |
| Q38835984 | Precision active pharmaceutical ingredients are the goal |
| Q44784411 | Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity |
| Q35894035 | Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor |
Search more.